Lensar (LNSR) Change in Account Payables (2019 - 2026)
Lensar's (LNSR) quarterly Change in Account Payables came in at -$3.9 million in Q1 2026, down 320.98% year-on-year from $1.8 million in Q1 2025, and down 192.81% on a QoQ basis from $4.2 million in Q4 2025.
Lensar (LNSR) Change in Account Payables (2019 - 2026) Analysis & Trends
Lensar (LNSR) has 8 years of Change in Account Payables data on file, last reported at -$3.9 million in Q1 2026.
- On a quarterly basis, Change in Account Payables fell 320.98% year-over-year to -$3.9 million in Q1 2026; TTM through Mar 2026 was $7.3 million, a 97.92% increase from a year earlier, with the FY2025 full-year figure at $13.0 million, up 563.96% from the prior year.
- Change in Account Payables for Q1 2026 stood at -$3.9 million, down from $4.2 million in the prior quarter.
- Over the last five years, Change in Account Payables for LNSR reached as high as $4.2 million in Q4 2025 and fell as low as -$3.9 million in Q1 2026.
- Historically, Change in Account Payables has averaged $727529.4 across 5 years, with a median of $97000.0 in 2024.
- Across the five-year window, Change in Account Payables sank 415.82% in 2023 and jumped 29216.67% in 2025, its largest moves.
- Year by year, Change in Account Payables stood at $1.9 million in 2022, then tumbled by 96.3% to $72000.0 in 2023, then jumped by 2809.72% to $2.1 million in 2024, then surged by 99.9% to $4.2 million in 2025, then plunged by 192.81% to -$3.9 million in 2026.
- Per Business Quant data, the three most recent Change in Account Payables figures were -$3.9 million in Q1 2026, $4.2 million in Q4 2025, and $3.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 221.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Lensar | 70.05 Mn | 72.73 Mn | 6.38 Mn | -3.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.89 Mn |
| Mar 31, 2026 | -3.89 Mn |
| Dec 31, 2025 | 4.19 Mn |
| Dec 31, 2025 | 4.19 Mn |
| Sep 30, 2025 | 3.48 Mn |
| Sep 30, 2025 | 3.48 Mn |
| Jun 30, 2025 | 3.56 Mn |
| Jun 30, 2025 | 3.56 Mn |
| Mar 31, 2025 | 1.76 Mn |
| Mar 31, 2025 | 1.76 Mn |
| Dec 31, 2024 | 2.10 Mn |
| Dec 31, 2024 | 2.10 Mn |
| Sep 30, 2024 | -242,000.00 |
| Sep 30, 2024 | -242,000.00 |
| Jun 30, 2024 | 97,000.00 |
| Jun 30, 2024 | 97,000.00 |
| Mar 31, 2024 | 6,000.00 |
| Mar 31, 2024 | 6,000.00 |
| Dec 31, 2023 | 72,000.00 |
| Dec 31, 2023 | 72,000.00 |